Moderna
MRNA
#1316
Rank
S$18.20 B
Marketcap
$47.07
Share price
2.84%
Change (1 day)
-66.82%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of December 2024 : S$14.54 Billion

According to Moderna 's latest financial reports the company has S$14.54 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$S$14.81 B-19.02%
2023-12-31$S$18.29 B-28.63%
2022-12-31$S$25.63 B34.06%
2021-12-31$S$19.12 B464.42%
2020-12-31$S$3.38 B113.91%
2019-12-31$S$1.58 B-24.24%
2018-12-31$S$2.09 B149.96%
2017-12-31$S$0.83 B-31.36%
2016-12-31$S$1.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$0.11 B-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$61.88 B 325.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$48.57 Million-100.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$89.52 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$58.88 B 304.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$74.83 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$95.40 B 555.81%๐Ÿ‡บ๐Ÿ‡ธ USA